Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Azusa Hisada"'
Autor:
Yukihiro Bando, Hitomi Tohyama, Keiko Aoki, Hideo Kanehara, Azusa Hisada, Kazuhiro Okafuji, Daisyu Toya
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 6, Iss C, Pp 1-7 (2016)
Aims: This preliminary randomized, parallel-group comparative study evaluated the efficacy of ipragliflozin for reduction of small dense low-density lipoprotein cholesterol (sd LDL-C) levels in Japanese patients with type 2 diabetes mellitus (T2DM).
Externí odkaz:
https://doaj.org/article/031132d3b0d742819c1bb8e226f969dc
Autor:
Daisyu Toya, Hideo Kanehara, Kazuhiro Okafuji, Yukihiro Bando, Azusa Hisada, Keiko Aoki, Hitomi Tohyama
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 6, Iss C, Pp 1-7 (2016)
Journal of Clinical & Translational Endocrinology
Journal of Clinical & Translational Endocrinology
Highlights • Small dense LDL-C (sd LDL-C) convey cardiovascular risk in type 2 diabetes (T2D). • Ipragliflozin reduced sd LDL-C levels in Japanese patients with T2D. • Changes in body weight, TG and LDL-C levels contributed to sd LDL-C reductio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2705cf18c04502c13f6d8001f5dd430a
https://doi.org/10.1016/j.jcte.2016.06.001
https://doi.org/10.1016/j.jcte.2016.06.001
Autor:
Yukihiro Bando, Kazuhiro Okafuji, Daisyu Toya, Keiko Aoki, Nobuyoshi Tanaka, Kousuke Shima, Hideo Kanehara, Azusa Hisada
Publikováno v:
Journal of Diabetes Mellitus. :28-35
Background: Treatment for postprandial glycemia using rapid-acting insulin analogues sometimes resulted in preprandial hypoglycemia or weight gain. Objective: This study evaluated the efficacy and safety of switching bolus insulin from insulin lispro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d79d2ad5a6b6f456b79d0fa9bd5442fb
https://doi.org/10.4236/jdm.2015.51004
https://doi.org/10.4236/jdm.2015.51004
Autor:
Yukihiro Bando, Kazuhiro Okafuji, Hideo Kanehara, Daisyu Toya, Nobuyoshi Tanaka, Masayuki Yamada, Azusa Hisada, Keiko Aoki
Publikováno v:
Diabetology International. 5:229-233
Aims This study assessed the independent predictors of the hemoglobin A1c (HbA1c)-lowering effect of vildagliptin in Japanese patients with type 2 diabetes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2c3ee395db6f2c1f478e09ca657c1c5
https://doi.org/10.1007/s13340-014-0161-3
https://doi.org/10.1007/s13340-014-0161-3
Autor:
Yukihiro Bando, Daisyu Toya, Nobuyoshi Tanaka, Keiko Aoki, Kazuhide Ishikura, Hideo Kanehara, Azusa Hisada
Publikováno v:
Diabetology International. 4:251-256
Aims This study assessed the independent predictors of the HbA1c-lowering effect of sitagliptin when added to ongoing insulin therapy in Japanese patients with type 2 diabetes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59e79630524e494f5e7fcbe1e5ef0252
https://doi.org/10.1007/s13340-013-0124-0
https://doi.org/10.1007/s13340-013-0124-0
Autor:
Hideo Kanehara, Kazuo Notumata, Kazuhide Ishikura, Azusa Hisada, Yukihiro Bando, Daisyu Toya, Kazuhiro Okafuji, Ayumi Ogawa
Publikováno v:
Diabetology international. 8(2)
We assessed the effects of a 12-week ipragliflozin treatment on the liver-to-spleen attenuation ratio (L/S ratio) using computed tomography and on alanine transaminase (ALT) levels in Japanese patients with type 2 diabetes mellitus (T2DM). Sixty-two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fffa8715a015a37f06e610e57742a34
https://pubmed.ncbi.nlm.nih.gov/30603325
https://pubmed.ncbi.nlm.nih.gov/30603325
Publikováno v:
Journal of Diabetes Investigation. 3:170-174
Aims/Introduction: The aim of the present study was to assess the independent predictors of the HbA1c-lowering effect of sitagliptin in Japanese type 2 diabetic patients. Materials and Methods: Data were retrieved from the medical records of 151 type
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3a6da810b5432ad8f744dee23f6139c
https://doi.org/10.1111/j.2040-1124.2011.00156.x
https://doi.org/10.1111/j.2040-1124.2011.00156.x
Autor:
Daisyu Toya, Azusa Hisada, Kazuhiro Okafuji, Yukihiro Bando, Nobuyoshi Tanaka, Hideo Kanehara, Hitomi Toyama
Publikováno v:
Diabetology international. 7(3)
This study investigated the independent predictors of the serum uric acid (sUA)-lowering effect of low-dose febuxostat, a novel xanthine oxidase inhibitor, in Japanese patients with type 2 diabetes mellitus (T2DM). Data of 130 T2DM patients who had b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de94078a7f696a35b6be0a07b8a520dc
https://pubmed.ncbi.nlm.nih.gov/30603278
https://pubmed.ncbi.nlm.nih.gov/30603278
Autor:
Kazuhiro Okafuji, Daisyu Toya, Azusa Hisada, Hideo Kanehara, Yukihiro Bando, Nobuyoshi Tanaka, Hitomi Toyama
Publikováno v:
Diabetes research and clinical practice. 111
Aims This open-label, randomized, parallel-group comparative study compared the efficacy of rosuvastatin (5 mg/day) and atorvastatin (10 mg/day) for reduction of small dense low-density lipoprotein cholesterol (sd LDL-C) levels in Japanese patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e043f198c2c0700d53ff9dfcdaec6b1
https://pubmed.ncbi.nlm.nih.gov/26589368
https://pubmed.ncbi.nlm.nih.gov/26589368
Autor:
Hideo Kanehara, Hitomi Wakaguri, Keiko Aoki, Yukihiro Bando, Daisyu Toya, Nobuyoshi Tanaka, Kazuhiro Okafuji, Azusa Hisada
Publikováno v:
Diabetology international. 7(1)
To determine whether non-high-density lipoprotein cholesterol (non-HDL-C) level, in comparison with low-density lipoprotein cholesterol (LDL-C) level, is useful for predicting the values of various surrogate atherosclerosis markers in Japanese subjec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e90c6b01703dcd633b2e7ba2f3ae3ba
https://pubmed.ncbi.nlm.nih.gov/30603241
https://pubmed.ncbi.nlm.nih.gov/30603241